MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ckj/sfaf344

Медицинская библиотека · Clinical kidney journal · 2025

Serum proteome analysis detects early molecular signatures of disease progression in IgA nephropathy.

Chen Tony Jialiang, Skandalou Eleni, Fritz-Wallace Katarina, Apeland Terje, Knoop Thomas, Marti Hans-Peter, Eikrem Øystein, Furriol Jessica

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Immunoglobulin A nephropathy (IgAN) is a common cause of chronic kidney disease (CKD) and identifying early molecular signatures is crucial for IgAN risk stratification and timely intervention. In this study we used serum proteomics to investigate molecular differences between IgAN patients who progressed and those who remained stable before separation in kidney function became apparent.

METHODS

Serum samples from 40 adults with biopsy-proven IgAN were analysed and classified as progressors (PRs; n = 13) or non-progressors (NPs; n = 27) based on the estimated glomerular filtration rate slope over a 5- to 6-year follow-up. Samples underwent protein depletion, SP3 digestion, tandem mass tag labelling and liquid chromatography-tandem mass spectrometry analysis. Differentially expressed proteins were identified using Welch's t-test. Enrichment analysis (Gene Ontology, Kyoto Encyclopedia of Genes and Genomes) was performed with ShinyGO and Cytoscape. Random forest machine learning was applied for classification modelling.

RESULTS

Fifty-two proteins showed a significant differential abundance between PRs and NPs. Enrichment analysis revealed dysregulation in complement cascade, extracellular matrix signalling and renin-angiotensin system in PRs compared with NPs. Finally, the random forest model on this protein set achieved an accuracy of 85.0% and identified NCAM1, F7, ARG1, CLU and ANXA5 among the most important predictors.

CONCLUSIONS

Serum proteomic profiling identified early molecular differences between PR and NP IgAN patients. These findings support the utility of serum proteomics for early risk stratification in IgAN.

Для цитирования: Chen Tony Jialiang, Skandalou Eleni, Fritz-Wallace Katarina, Apeland Terje, Knoop Thomas, Marti Hans-Peter, Eikrem Øystein, Furriol Jessica. Serum proteome analysis detects early molecular signatures of disease progression in IgA nephropathy.. Clinical kidney journal. 2025. DOI: 10.1093/ckj/sfaf344.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.